Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations

Neurosurgical Focus

Volumn 29, Issue 3, 2010, Pages 1-8

  Zhu, Yuan ^a   Wu, Qun ^a,b   Xu, Jin Fang ^a,b   Miller, Dorothea ^a   Erol Sandalcioglu, I ^a   Zhang, Jian Min ^b   Sure, Ulrich ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenesis; CCM2; CCM3; Cerebral cavernous malformation; Short interfering RNA

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CCM2 PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; PDCD10 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ADULT; ARTICLE; BIOLOGICAL MODEL; BRAIN HEMANGIOMA; COMPARATIVE STUDY; ENDOTHELIUM CELL; FEMALE; GENE SILENCING; GENETICS; HUMAN; MALE; MUTATION; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ADULT; APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; ENDOTHELIAL CELLS; FEMALE; GENE SILENCING; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; MALE; MEMBRANE PROTEINS; MODELS, GENETIC; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 77956215712     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2010.5.FOCUS1090     Document Type: Article

References (31)

1. Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA: Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18:919-930, 2009
2. Baev NI, Awad IA: Endothelial cell culture from human cerebral cavernous malformations. Stroke 29:2426-2434, 1998
3. Borikova AL, Dibble CF, Sciaky N, Welch CM, Abell AN, Bencharit S, et al: Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem 285:11760-11764, 2010
4. Boulday G, Blécon A, Petit N, Chareyre F, Garcia LA, Niwa-Kawakita M, et al: Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis Model Mech 2:168-177, 2009
5. Chen L, Tanriover G, Yano H, Friedlander R, Louvi A, Gunel M: Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3. Stroke 40:1474-1481, 2009
6. Crose LE, Hilder TL, Sciaky N, Johnson GL: Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J Biol Chem 284:13301-13305, 2009
7. Dashti SR, Hoffer A, Hu YC, Selman WR: Molecular genetics of familial cerebral cavernous malformations. Neurosurg Focus 21(1):e2, 2006
8. Denier C, Labauge P, Bergametti F, Marchelli F, Riant F, Ar-noult M, et al: Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann Neurol 60:550-556, 2006
9. Glading A, Han J, Stockton RA, Ginsberg MH: KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 179:247-254, 2007
10. Harel L, Costa B, Tcherpakov M, Zapatka M, Oberthuer A, Hansford LM, et al: CCM2 mediates death signaling by the TrkA receptor tyrosine kinase. Neuron 63:585-591, 2009
11. Hilder TL, Malone MH, Bencharit S, Colicelli J, Haystead TA, Johnson GL, et al: Proteomic identification of the cerebral cavernous malformation signaling complex. J Proteome Res 6: 4343-4355, 2007
12. Hogan BM, Bussmann J, Wolburg H, Schulte-Merker S: ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum Mol Genet 17:2424-2432, 2008
13. Kleaveland B, Zheng X, Liu JJ, Blum Y, Tung JJ, Zou Z, et al: Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 15:169-176, 2009
14. Ma X, Zhao H, Shan J, Long F, Chen Y, Chen Y, et al: PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol Biol Cell 18:1965-1978, 2007
15. Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Pérez-del-Pulgar S, et al: Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvasc Res 66:102-112, 2003
16. Pagenstecher A, Stahl S, Sure U, Felbor U: A two-hit mechanism causes cerebral cavernous malformations: complete in-activation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 18:911-918, 2009
17. Patterson C: Torturing a blood vessel. Nat Med 15:137-138, 2009
18. Petit N, Blécon A, Denier C, Tournier-Lasserve E: Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. Gene Expr Patterns 6:495-503, 2006
19. Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, Marchuk DA: Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am J Pathol 165:1509-1518, 2004
20. Plummer NW, Squire TL, Srinivasan S, Huang E, Zawistowski JS, Matsunami H, et al: Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm Genome 17:119-128, 2006
21. Revencu N, Vikkula M: Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet 43:716-721, 2006
22. Risau W: Mechanisms of angiogenesis. Nature 386:671-674, 1997
23. Seker A, Pricola KL, Guclu B, Ozturk AK, Louvi A, Gunel M: CCM2 expression parallels that of CCM1. Stroke 37:518-523, 2006
24. Tonelli A, Lanfranconi S, Bersano A, Corti S, Bassi MT, Bre-solin N: Aberrant splicing due to a silent nucleotide change in CCM2 gene in a family with cerebral cavernous malformation. Clin Genet 75:494-497, 2009
25. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, et al: The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15:177-184, 2009
26. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY: Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131:1437-1448, 2004
27. Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, et al: CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14:2521-2531, 2005
28. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC: Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10: 2953-2960, 2001
29. Zhao Y, Tan YZ, Zhou LF, Wang HJ, Mao Y: Morphological observation and in vitro angiogenesis assay of endothelial cells isolated from human cerebral cavernous malformations. Stroke 38:1313-1319, 2007
30. Zhu Y, Peters C, Hallier-Neelsen M, Miller D, Pagenstecher A, Bertalanffy H, et al: Phosphatase and tensin homolog in cerebral cavernous malformation: a potential role in pathological angiogenesis. Laboratory investigation. J Neurosurg 110:530-539, 2009
31. Zhu Y, Wloch A, Wu Q, Peters C, Pagenstecher A, Bertalanffy H, et al: Involvement of PTEN promoter methylation in cerebral cavernous malformations. Stroke 40:820-826, 2009